dgn-np:NP114219.RA_d9pt1oqx0hQCY6q6qVW8Ix3aP7ydvor0R7h4m7BydE130_provenance {
  dgn-np:NP114219.RA_d9pt1oqx0hQCY6q6qVW8Ix3aP7ydvor0R7h4m7BydE130_assertion dcterms:description "[In a cohort of 55 breast cancer patients, activation of the PI3K pathway, as judged by the presence of oncogenic PIK3CA mutations or low PTEN expression, was associated with poor prognosis after trastuzumab therapy, and the combined analysis of PTEN and PIK3CA identified twice as many patients at increased risk for progression compared to PTEN alone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ;
    wi:evidence dgn-void:source_evidence_literature ;
    sio:SIO_000772 miriam-pubmed:17936563 ;
    prov:wasDerivedFrom dgn-void:gad-20150221 ;
    prov:wasGeneratedBy eco:ECO_0000203 .
  dgn-void:gad-20150221 pav:importedOn "2015-02-21"^^xsd:date .
  dgn-void:source_evidence_literature a eco:ECO_0000212 ;
    rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ;
    rdfs:label "DisGeNET evidence - LITERATURE"@en .
}